Leveraging Technology to Elevate Patient Reporting Adherence in Vaccine Clinical Trials: Reaching +98% Adherence Rates

Leveraging Technology to Elevate Patient Reporting

Poor patient reporting adherence can prolong the trial duration by increasing the time required to gather complete and accurate data. This can extend the overall cost of the trial while burdening the study team and site, and compromise future submissions.

 

Patient reporting adherence facilitates the early identification of symptoms and risk factors, prevents dropouts, and increases patient safety overall. Moreover, it enhances the trial results with accurate and reliable data for a sucessfull trial.

 

But, how increase patient reporting adherenece?

 

Here we share 3 ways TrialPal eCOA and ePRO has achieve to mantained +98% of patient reporting adherence in complex vaccine clinical trials:

Forms & Surveys

eDiaries and symptom reporting are vital for clinical trials, especially for vaccines. TrialPal enhances clinical data but also enables the collection of other kinds of data with linked forms, such as demographics, symptom details, group assessments, and lifestyle factors. Allowing reporting multiple times, even in one day, on the same APP.

Notifications & Alerts

TrialPal has a robust notification and alert system that is highly customizable and protocol-specific. On one hand, having real-time alerts helps the team address issues faster, and on the other, notifications help participants be more precise, report within windows, and be aware of their care.

Participant Friendly

TrialPal has a robust notification and alert system that is highly customizable and protocol-specific. On one hand, having real-time alerts helps the team address issues faster, and on the other, notifications help participants be more precise, report within windows, and be aware of their care.

Engaging with participants is easier with TrialPal eCOA and ePRO thanks to features like an intuitive design, mobile and web access, dark mode and offline mode. Best of all, we can lead a tech-adoption educational strategy for patients in their own language.

Integra IT’s TrialPal is the eCOA and ePRO solution specifically tailored to the unique needs of vaccine clinical trials. Its adaptable design seamlessly integrates with any study protocol, ensuring comprehensive data collection, enhanced participant engagement, and robust analytics for study teams.

For your next trial, partner with Integra IT and experience the power of TrialPal!

Share This Post

More To Explore

Are you planning your site's 2024 budget Trial 360
Resources

Are you planning your site’s 2024 budget?

Around this season, many research sites are planning and projecting their budget for the upcoming year 2024; this is an excellent opportunity to consider a